VOLITIONRX LTD — Director's Dealing 2020

Aug 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-08-12

Reporting Person: Innes Guy Archibald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-12	Common Stock	M	15000	$2.5	Acquired	1369975	Direct
2020-08-12	Common Stock	M	15000	$3	Acquired	1384975	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-12	Stock Option (Right to Buy)	$2.5	M	15000	Disposed	2020-08-18	Common Stock (15000)	Direct
2020-08-12	Stock Option (Right to Buy)	$3	M	15000	Disposed	2020-08-18	Common Stock (15000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	49726	Indirect

Footnotes

F1: The foregoing shares are held by a bare trust, which is not a separate legal entity, of which the Reporting Person is the Trustee, for the benefit of certain minors.